We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with psychiatric disorders.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
Guidance for prescribing vets on the use of the cascade.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Teva UK Ltd. has informed the MHRA of a labelling error. This notification provides further advice on the safe use of the product.
Check what side effects people have reported when they've taken a medicine.
Collection of information and guidance for patients and for healthcare professionals on the reproductive risks of valproate and new safety measures introduced to reduce these risks.
Guidance and support on coronavirus (COVID-19) in Scotland.
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
This guidance identifies common issues with validation and assessment of clinical trial applications and how to avoid them.
You must tell DVLA about your depression if it affects your driving - download the correct form to let them know
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
You must tell DVLA if you have severe depression: how to report it to DVLA, what form to download and send depending on the vehicle you drive.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
This page provides a collection of online media literacy resources and events.
Information on COVID-19, including guidance on the assessment and management of suspected UK cases.
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.